|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/09 | (2006.01) |
| A61K 39/385 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3096786 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15708581.2 |
| Date of filing the European patent application | 2015-01-15 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/050316 |
| Date | 2015-01-15 |
| (87) | Number | WO 2015/110942 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| 201461929561 P | 2014-01-21 | US |
| (72) |
HAN, Mingming , US
PRASAD, Avvari Krishna , US
COOPER, David , US
WATSON, Wendy Jo , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF |
| STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF |